PATHOGENESIS OF VASCULAR MALFORMATIONS IN HEREDITARY HEMORRHAGIC TELANGIECTASIA: FROM DISEASE MECHANISM TO NEW THERAPIES

$9,933,291FY2017Defense Health AgencyDOD

Dignity Health, San Francisco CA

Investigators